An evaluation of current cholera treatment
- PMID: 12562304
- DOI: 10.1517/14656566.4.2.141
An evaluation of current cholera treatment
Abstract
Cholera, caused by Vibrio cholerae O1 and O139, is characterised by profuse purging of watery stools, and vomiting and dehydration. The mainstay of therapy of cholera patients is rehydration with oral rehydration salt solution or intravenous Ringer's lactate depending upon the degree of dehydration. Antibiotics such as tetracycline, doxycycline, norfloxacin, ciprofloxacin and furazolidone may be used as an adjunct to rehydration therapy for severely purging cholera patients to reduce the rate of stool output. This shortens the duration of hospital stay, stops excretion of vibrios in the stool and minimises the requirement of fluids. Resistance to many of these drugs has been observed and is a matter of concern. Other antidiarrhoeals are not recommended. Many antisecretory drugs have been tried as an adjunct therapy, unfortunately, until today, none has been found useful in the treatment of cholera. Feeding during and after cholera is emphasised.
Similar articles
-
Randomised double blind trial of single dose doxycycline for treating cholera in adults.BMJ. 1990 Jun 23;300(6740):1619-21. doi: 10.1136/bmj.300.6740.1619. BMJ. 1990. PMID: 2196962 Free PMC article. Clinical Trial.
-
Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.BMJ. 1992 Feb 1;304(6822):287-91. doi: 10.1136/bmj.304.6822.287. BMJ. 1992. PMID: 1531430 Free PMC article.
-
Management of acute diarrhoea.Indian J Med Res. 1996 Jul;104:96-102. Indian J Med Res. 1996. PMID: 8783511 Review.
-
Comparison of glucose/electrolyte and maltodextrin/glycine/glycyl-glycine/electrolyte oral rehydration solutions in cholera and watery diarrhoea in adults.Ann Trop Med Parasitol. 1991 Dec;85(6):645-50. doi: 10.1080/00034983.1991.11812620. Ann Trop Med Parasitol. 1991. PMID: 1811441 Clinical Trial.
-
Practical guidelines for the treatment of cholera.Drugs. 1996 Jun;51(6):966-73. doi: 10.2165/00003495-199651060-00005. Drugs. 1996. PMID: 8736618 Review.
Cited by
-
Natural-Product-Based Solutions for Tropical Infectious Diseases.Clin Microbiol Rev. 2021 Dec 15;34(4):e0034820. doi: 10.1128/CMR.00348-20. Epub 2021 Sep 8. Clin Microbiol Rev. 2021. PMID: 34494873 Free PMC article. Review.
-
Antibiotic susceptibility profiles of some Vibrio strains isolated from wastewater final effluents in a rural community of the Eastern Cape Province of South Africa.BMC Microbiol. 2010 May 14;10:143. doi: 10.1186/1471-2180-10-143. BMC Microbiol. 2010. PMID: 20470419 Free PMC article.
-
Vibrio fluvialis: an unusual enteric pathogen of increasing public health concern.Int J Environ Res Public Health. 2010 Oct;7(10):3628-43. doi: 10.3390/ijerph7103628. Epub 2010 Oct 12. Int J Environ Res Public Health. 2010. PMID: 21139853 Free PMC article. Review.
-
Vibrio Pathogenicity Island-1: The Master Determinant of Cholera Pathogenesis.Front Cell Infect Microbiol. 2020 Oct 6;10:561296. doi: 10.3389/fcimb.2020.561296. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33123494 Free PMC article. Review.
-
Vaxchora: The First FDA-Approved Cholera Vaccination in the United States.P T. 2017 Oct;42(10):638-640. P T. 2017. PMID: 29018300 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical